================================================================================
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. 1)*
FREDERICK BREWING CO.
----------------------------------
(Name of Issuer)
COMMON STOCK, $0.00004 PAR VALUE PER SHARE
--------------------------------------------
(Title of Class of Securities)
355673-10-4
----------------
(CUSIP Number)
Jeffrey A. Koeppel, Esq.
Elias, Matz, Tiernan & Herrick L.L.P.
734 15th Street, N.W.
Washington, D.C. 20005
(202) 347-0300
-------------------------------------------------------
(Name, Address, Telephone Number of Person Authorized
to Receive Notices and Communications)
September 5, 1997
--------------------------------------------------------
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report
the acquisition which is the subject of this Schedule 13D, and is filing this
schedule because of Rule 13d-1(b)(3) or (4), check the following box [ ].
Check the following box if a fee is being paid with the statement [ ]. (A fee is
not required only if the reporting person: (1) has a previous statement on file
reporting beneficial ownership of more than five percent of the class of
securities described in Item 1; and (2) has filed no amendment subsequent
thereto reporting beneficial ownership of five percent or less of such class.)
(See Rule 13d-7.)
================================================================================
<PAGE>
- -------------------------------------- ------------------------------------
CUSIP NO. 355673-10-4 Page 2 of 5 Pages
- -------------------------------------- ------------------------------------
- --------------------------------------------------------------------------------
1. NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Nicholas P. Foris, M.D.
- --------------------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) / /
(b) / /
- --------------------------------------------------------------------------------
3. SEC USE ONLY
- --------------------------------------------------------------------------------
4. SOURCE OF FUNDS
PF
- --------------------------------------------------------------------------------
5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS PURSUANT TO
ITEMS 2(d) or 2(e) / /
Not Applicable
- --------------------------------------------------------------------------------
6. CITIZENSHIP OR PLACE OF ORGANIZATION
United States of America
- --------------------------------------------------------------------------------
7. NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
SOLE VOTING POWER
139,547
- --------------------------------------------------------------------------------
8. NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
SHARED VOTING POWER
-0-
- --------------------------------------------------------------------------------
9. NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH SOLE
DISPOSITIVE POWER
139,547
- --------------------------------------------------------------------------------
10. NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
SHARED DISPOSITIVE POWER
-0-
- --------------------------------------------------------------------------------
11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
139,547
-------------------------------------------------------------------------------
12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN
SHARES / /
- --------------------------------------------------------------------------------
13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
5.0%
- --------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON
IN
- --------------------------------------------------------------------------------
<PAGE>
- -------------------------------------- ------------------------------------
CUSIP NO. 355673-10-4 Page 3 of 5 Pages
- -------------------------------------- ------------------------------------
Amendment No. 1 to SCHEDULE 13D
This Statement ("Amendment No. 1") amends the Schedule 13D originally filed on
March 5, 1996 ("Schedule 13D") by Nicholas P. Foris, M.D. with respect to the
shares of Common Stock, $0.00004 par value per share ("Common Stock"), of
Frederick Brewing Co. (the "Issuer"), a Maryland corporation. All defined terms
refer to terms defined herein and in the Schedule 13D. The Schedule 13D is
amended only to the extent set forth below.
Item 1. Security and Issuer
- ---------------------------
The address of the Issuer's principal executive office is 4607 Wedgewood
Boulevard, Frederick, Maryland 21703.
Item 3. Source and Amount of Funds or Other Consideration
- ---------------------------------------------------------
Dr. Foris purchased 210 shares of the Issuer's 8% Cumulative Convertible
Preferred Stock, Series A, ("Preferred Stock") in a private transaction. The
aggregate cost of the Preferred Stock was $54,706.00. The Preferred Stock is
convertible into 27,353 shares of the Issuer's Common Stock beginning on
February 28, 1998 at an exercise price of $2.00 per share of Common Stock.
The funds used by the reporting person filing this Statement to purchase shares
of Common Stock, have come from such reporting person's personal funds, which
include cash and cash equivalents on hand and in banks.
Item 5. Interest in Securities of the Issuer
- -------------------------------------------
(a) As of the date hereof, Dr. Foris may be deemed to be the beneficial owner
of an aggregate of 139,547 shares of Common Stock, which constitutes
approximately 5.0% of the 2,768,735 shares of Common Stock which Dr.
Foris believes to be the total number of Common Stock outstanding as of
July 31, 1997 as reported in the Issuer's Form 10Q-SB. The directly owned
shares of Common Stock are held by Dr. Foris in a personal account.
Nothing contained herein shall be construed as an admission that Dr.
Foris is the beneficial owner of any shares of Common Stock, except as
set forth herein as expressly and admittedly being beneficially owned by
Dr. Foris. Except as described herein, to the best knowledge of Dr. Foris
no person who may be deemed to comprise a group with Dr. Foris,
beneficially owns any shares of Common Stock.
(b) The reporting person filing this Statement has the sole power to vote and
dispose of the 139,547 shares of Common Stock, owned by such reporting
person as of September 5, 1997.
<PAGE>
- -------------------------------------- ------------------------------------
CUSIP NO. 355673-10-4 Page 4 of 5 Pages
- -------------------------------------- ------------------------------------
(c) The reporting person filing this Statement has not effected any
transactions in the Common Stock, within the past 60 days.
(d) No person other than the reporting person filing this Statement has the
right to receive, or the power to direct the receipt of, dividends from,
or the proceeds from the sale of, the shares of Common Stock, reported in
this Statement.
(e) Not applicable.
<PAGE>
- -------------------------------------- ------------------------------------
CUSIP NO. 355673-10-4 Page 5 of 5 Pages
- -------------------------------------- ------------------------------------
SIGNATURES
After reasonable inquiry and to the best of the knowledge and belief of the
undersigned, the undersigned certifies that the information set forth in this
Statement on Schedule 13D is true, complete and correct.
By: /s/ Nicholas P. Foris, M.D.
---------------------------
Nicholas P. Foris, M.D.
Date: September 5, 1997
